DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Baas JM, Krens LL, Bos MM. et al.
Safety and efficacy of the addition of simvastatin to cetuximab in previously
treated KRAS mutant metastatic colorectal cancer patients.
Anticancer Drugs 2015;
26: 872-877
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.